Preventive medicine, precision medicine, and personalized medicine are the key words that penetrate the future healthcare industry. Microbiome-related biotechnology is the growth engine of the future health care industry, and it is the core of this industry. AtoGen Co., Ltd. has developed a self-developed functional material screening platform and NGS (Next Generation Sequencing technology) to analyze the metagenome, and we are researching and developing new drugs and functional food materials to treat various diseases and improve health.
Research capacity construction for each research theme
Targeted therapeutic microbes
Screening technics & Whole genome analysis techology